• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新配制的硕大利什曼原虫初步疫苗在动物模型Balb/c和普通小白实验室小鼠中的安全性和毒性

Safety and toxicity of a new formulated Leishmania major preliminary vaccine in animal model Balb/c and small white conventional laboratory mice.

作者信息

Latifynia Afshineh, Hazrati Saleh Mohaghegh

机构信息

University of Tehran School of Medicine, Medical Sciences, Tehran, Iran.

出版信息

Turkiye Parazitol Derg. 2008;32(2):103-8.

PMID:18645937
Abstract

Leishmania parasites cause a spectrum of diseases that afflict the populations of 88 countries around the world and all attempts to control leishmaniasis have failed. It seems that preparing a vaccine may be the final solution. The aim of this study was to determine various Leishmania (L.) major antigens vaccine candidates and effects of the vaccine on delayed type hypersensitivity (DTH). Many different methods of vaccine preparation plus or without adjuvant were used. We prepared crude antigen combinations by five different methods using antigens from L. major parasites. Phase I was done in animals. The immunogenic effect was evaluated with the delayed type hypersensitivity (DTH) reaction with five different doses, including 100, 200, 300, 400, 500 microg/ml of total protein + BCG in Balb/c and conventional laboratory white mice (out breed). Our results showed that the cocktail antigen was highly specific. No injection of BCG solvent or saline treated controls showed significant results. Taken together, the effect of cellular immune response to the cocktail vaccine induced a significant effect against cutaneous leishmaniasis in the experimental model of vaccine with L. major.

摘要

利什曼原虫寄生虫引发了一系列疾病,困扰着全球88个国家的民众,所有控制利什曼病的尝试均告失败。制备疫苗似乎可能是最终的解决办法。本研究的目的是确定多种利什曼原虫(硕大利什曼原虫)主要抗原疫苗候选物以及该疫苗对迟发型超敏反应(DTH)的影响。使用了许多不同的制备疫苗方法,有加佐剂的和不加佐剂的。我们使用硕大利什曼原虫寄生虫的抗原,通过五种不同方法制备了粗抗原组合。第一阶段在动物身上进行。用迟发型超敏反应(DTH)评估免疫原性效应,使用五种不同剂量,包括在Balb/c小鼠和常规实验室白色小鼠(远交群)中每毫升含100、200、300、400、500微克总蛋白 + 卡介苗。我们的结果表明,混合抗原具有高度特异性。未注射卡介苗溶剂或生理盐水处理的对照组未显示出显著结果。综上所述,在硕大利什曼原虫疫苗实验模型中,细胞免疫反应对混合疫苗的作用诱导了针对皮肤利什曼病的显著效果。

相似文献

1
Safety and toxicity of a new formulated Leishmania major preliminary vaccine in animal model Balb/c and small white conventional laboratory mice.一种新配制的硕大利什曼原虫初步疫苗在动物模型Balb/c和普通小白实验室小鼠中的安全性和毒性
Turkiye Parazitol Derg. 2008;32(2):103-8.
2
Evaluation of the effects of a new formulation of Leishmania major antigen in Balb/C and conventional white laboratory mice.评估新型利什曼原虫抗原配方在 Balb/C 和常规白色实验小鼠中的效果。
J Microbiol Immunol Infect. 2010 Apr;43(2):138-46. doi: 10.1016/S1684-1182(10)60022-9.
3
Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.利什曼病的传播阻断疫苗研究:II. 使用硕大利什曼原虫来源的63千道尔顿糖蛋白、脂磷壁酸糖和全寄生虫抗原免疫对BALB/c小鼠硕大利什曼原虫感染进程的影响。
East Afr Med J. 2001 Feb;78(2):90-2.
4
Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice.评估Toll样受体4和7/8激动剂在BALB/c小鼠利什曼病疫苗中的佐剂作用。
Mol Immunol. 2017 Nov;91:202-208. doi: 10.1016/j.molimm.2017.09.010. Epub 2017 Sep 30.
5
Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model.分泌白蛉唾液抗原PpSP15的大利什曼原虫在易感的BALB/c小鼠模型中可提供针对硕大利什曼原虫感染的保护作用。
Mol Immunol. 2015 Oct;67(2 Pt B):501-11. doi: 10.1016/j.molimm.2015.08.001. Epub 2015 Aug 19.
6
Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis.评价免疫应答,并分析利什曼原虫重组核糖体蛋白 L3 或 L5 疫苗接种对两种不同皮肤利什曼病小鼠模型的影响。
Vaccine. 2013 Feb 18;31(9):1312-9. doi: 10.1016/j.vaccine.2012.12.071. Epub 2013 Jan 10.
7
Post challenging serum cytokine profile (Th1 & Th2) in the vaccinated mice (Balb/C) with a new formulation of Leishmania major antigen.用新型利什曼原虫主要抗原制剂对接种疫苗的小鼠(Balb/C)进行激发后血清细胞因子谱(Th1和Th2)分析
Turkiye Parazitol Derg. 2013;37(4):233-40. doi: 10.5152/tpd.2013.2988.
8
Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection.DNA 和蛋白质利什曼原虫γ-谷氨酰半胱氨酸合成酶疫苗对预防大疱性皮肤利什曼病或墨西哥利什曼原虫感染引起的小鼠皮肤利什曼病的交叉保护作用的比较评估。
Vaccine. 2012 Feb 8;30(7):1357-63. doi: 10.1016/j.vaccine.2011.12.067. Epub 2011 Dec 28.
9
Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.在感染巴西利什曼原虫(维安尼亚种)的小鼠模型中对四种利什曼原虫疫苗候选物进行测试,巴西利什曼原虫(维安尼亚种)是新世界皮肤利什曼病的主要病原体。
Clin Vaccine Immunol. 2007 Sep;14(9):1173-81. doi: 10.1128/CVI.00060-07. Epub 2007 Jul 11.
10
Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.用婴儿利什曼原虫酸性核糖体P0蛋白加CpG寡脱氧核苷酸进行疫苗接种可诱导C57BL/6小鼠对皮肤利什曼病产生保护作用,但不能预防BALB/c小鼠的进行性疾病。
Infect Immun. 2005 Sep;73(9):5842-52. doi: 10.1128/IAI.73.9.5842-5852.2005.

引用本文的文献

1
Visceral leishmaniasis in a patient with cutaneous lesions, negative Leishman-Donovan bodies and immunological test: A case report.一名患有皮肤病变、利什曼-多诺万小体阴性且免疫检测呈阴性的患者的内脏利什曼病:病例报告
J Res Med Sci. 2011 Nov;16(11):1507-10.